APP and microcephaly: We have proposed a role for APP and in particular nonamyloidogenic sAPPα, in brain overgrowth and macrocephaly in ASD (Sokol et al., 2019), and presently we look to the amyloidogenic pathway to explain microcephaly in ASD.